Vaccine shortages arise across U.S., halting inoculations in some places
By Peter Szekely NEW YORK (Reuters) - Scattered vaccine shortages cropped up on the frontlines of the U.S. battle against the coronavirus pandemic on Friday, prompting at least one large New York healthcare system to cancel a slew of appointments of people hoping to be inoculated. The supply-chain blips arose as the country struggles to speed up the pace of vaccinations.
By Peter Szekely
NEW YORK (Reuters) - Scattered vaccine shortages cropped up on the frontlines of the U.S. battle against the coronavirus pandemic on Friday, prompting at least one large New York healthcare system to cancel a slew of appointments of people hoping to be inoculated.
The supply-chain blips arose as the country struggles to speed up the pace of vaccinations. Only 12.3 million doses have been administered, with only 10.6 million people having received at least one of the two required shots, according to the Centers for Disease Control and Prevention (CDC).
In New York, the country's most populous city, Mayor Bill de Blasio said the city has vaccinated about 300,000 of its more than 8 million residents, but was on course to run dry next week because it was burning through vaccines faster than they were being replenished.
"We've been getting resupply right now at a very paltry level of about 100,000 doses a week," de Blasio said on WNYC radio. "We went through 125,000 in the first four days of this week, and our numbers are increasing every day."
In Oregon, Governor Kate Brown said a federal official told her the state would not receive additional vaccine supplies because the federal government has none in reserve.
"I am demanding answers from the Trump administration," Brown said on Twitter.
Similarly, Colorado Governor Jared Polis said he was "extremely disappointed" that the U.S. Department of Health and Human Services "lied to" his state about promised reserved, second doses of the vaccine.
Earlier this week, Health and Human Services Secretary Alex Azar said the federal government would begin distributing a reserve of vaccines to states, a position also taken by the incoming administration of President-elect Joe Biden, which takes over on Jan. 20.
However, the Washington Post reported on Friday morning that the federal government does not have a remaining reserve of the two approved vaccines, one by Pfizer Inc and partner BioNTech and a second from Moderna Inc, which has emergency use authorization.
Citing unidentified officials, the Post reported the reserve, which the federal government said was initially set aside for the second doses that each vaccine requires, had already been distributed starting in late December.
HHS did not respond immediately to a request for comment. Senior administration officials told the New York Times later on Friday that all of the reserve doses were already dedicated to people who had gotten a first shot, and that Azar had been spelling out the logical extension of its December policy to earmark doses for second shots.
DIRECT TO CITIES
De Blasio, who said vaccine supplies should be allocated to localities commensurate with their ability to administer them, was among three dozen big city mayors who have asked the incoming Biden administration to send COVID-19 vaccine shipments directly to them, bypassing state governments. [L1N2JP36J]
At least one New York City healthcare system canceled vaccination appointments and another suspended new ones amid shortages. A Mount Sinai Hospital spokeswoman said "sudden changes in vaccine supply" forced it to cancel appointments through next Tuesday.
NYU Langone Health suspended new appointments beginning Friday after state and local officials abruptly declined to provide routine confirmation that it and other healthcare systems would get any more vaccine, Senior Vice President Andrew Rubin said.
“I don't know what's happening,” Rubin said by telephone. “And we would really like to get our allocations.”
Rubin declined to reveal the number of doses NYU Langone usually received, but said its three hospitals and 12 other locations in New York City and Long Island have vaccinated 36,000 people, and have the capacity to handle 5,000-7,000 a day.
Biden on Friday said he would order increased production of syringes and other supplies to ramp up vaccinations against COVID-19 and improve upon the Trump administration's vaccine rollout that he has called a "dismal failure."
Under Biden's plan, federal disaster-relief workers would set up thousands of centers, where retired doctors would administer shots to teachers, grocery store workers, people over 65 years old and other groups who do not currently qualify under current vaccination guidelines.
Since the onset of the pandemic, the virus has infected 23.1 million Americans, about 7% of the population, killing 388,467 of them, according to a Reuters tally.
New York Governor Andrew Cuomo blamed the supply gaps on the federal government, which he said had cut supplies this week to 250,000 doses from 300,000, while expanding the eligibility to include 7 million of the state's 19 million residents.
"They increased the eligibility, they did not increase the supply,” Cuomo said at a briefing.
According to the CDC, New York state has administered only about 757,000 doses of the 1.9 million it has received.
(Reporting by Peter Szekely; Additional reporting by Barbara Goldberg in Maplewood, New Jersey, Nathan Layne in Wilton, Connecticut, Rebecca Spalding in New York; Brendan O'Brien in Chicago and Anurag Maan in Bangalore; Editing by Aurora Ellis)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply
By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.
(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.
By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.